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Abstract
Background: Increasing evidences have indicated that there are gender differences in the prevalence of metabolic
syndrome(MS), but the mechanism is uncertain.
Methods: A total of 711 subjects aged 35–65 years accepted health examinations both in 1992 and 2007. Since
114 subjects had MS and 7 had heart disease at baseline, they were excluded from the analysis. Therefore, 590
subjects with complete data (male: 61.5 %) were available and analysed. After the relationship between gender and
incident MS at follow-up was tested, these subjects were categorized into four groups according to the baseline
resting heart rate(RHR) classified by genders. Trend tests of MS incidences across the four groups of resting heart
rate were conducted by Cochran-Armitage tend tests in both men and women. Additionally, three logistic
regression models were used to estimate the effects of RHR on the new onset of MS by taking RHR as a
continuous variable(per 4 beats/min elevation).
Results: Gender(women) itself was an independent risk factor for incident MS at follow-up(OR = 2.64, 1.33–5.23,
P = 0.005). The incidences of MS according to the RHR categories showed a statistical linear trend in women(P for
trend = 0.018) rather than in men(P for trend = 0.194). The ORs[95 % confidence intervals(CIs)] of MS for each 4 bpm
elevation in RHR was 1.18(1.03–1.36)(P = 0.020) in a univariate model, 1.20 (1.04–1.38) (P = 0.011) adjusted for age
and health related behaviors only and 1.23(1.06–1.43)(P = 0.007) adjusted for age, health related behaviors and
pre-existing components of MS in the baseline in women. Otherwise, RHR did not have any significant associations
with incident MS in men neither in a univariate model nor in multivariate models.
Conclusions: In this study, elevated RHR is correlated with the development of MS in women rather than in men.
Keywords: Resting heart rate, Metabolic syndrome, Sympathetic activity, Gender differences
Background
The metabolic syndrome(MS) is defined as a combination
of interrelated cardiovascular disease(CVD) risk factors in-
cluding abdominal obesity, hyperglycemia, raised blood
pressure, elevated triglyceride and decreased high-density
lipoprotein cholesterol [1]. Patients with the metabolic
syndrome are at more than twice the risk of developing
CVD over the next 5–10 years compared with those
without the syndrome [1, 2]. Obviously, along with the
modern life style changing, MS is becoming a major global
public health problem which actually can be prevented.
Accordingly, it is important to find the probably risk
factors of the aggregation of multiple CVD risk factors so
as to prevent the development of MS.
Increasing evidences have indicated that there are gen-
der differences in the prevalence of MS [3–6]. The preva-
lence of MS in postmenopausal women is higher than that
in men at the same age, but the mechanism is uncertain.
Maybe there are some differences in the pathogenesis of
the aggregation of multiple CVD risk factors in different
genders. Several short-term follow-up studies [7, 8] have
indicated that resting heart rate(RHR), which is a widely
accepted indicator of sympathetic activity, is a significant
risk factor of incident MS in men but not in women, but
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they could not give a good explanation for the differences.
On the other hand, some studies [9–11] have found that
body reactions of sympathetic activation are elevated sig-
nificantly in women after menopause, which means,
prolonging the follow-up period may get a different result
of the relationship between RHR and incident MS in
women. In order to clarify these issues, we utilized our
data of a long-term longitudinal follow-up cohort in our
Chinese people. We also used RHR as the indicator of
sympathetic activity.
Methods
Participants and risk factors measurements
The study population was a part of the Chinese Multi-
provincial Cohort Study(CMCS) in an urban community
located in Chengdu, Sichuan province. A total of 711 sub-
jects aged 35–65 years in the baseline accepted health
examinations both in 1992(baseline) and 2007(follow-up)
for cardiovascular disease (CVD) risk factors according to
the World Health Organization-Multinational Monitoring
of Trends and Determinants in Cardiovascular Diseases
(WHO-MONICA) [12]. This includes a standardized ques-
tionnaire, physical examinations and laboratory tests. The
questionnaire included demographic characteristics, smok-
ing status, alcohol consumption, physical activity, and
medical history of diabetes, hypertension and heart disease
(coronary artery disease, heart failure or arrhythmia), but
the details of anti-hypertensive medication were unavail-
able. Physical examinations included blood pressure, heart
rate, height, weight and waist circumference measure-
ments. After at least 5-min of rest in seated position, rest-
ing heart rate was obtained by pulse palpation over a 30-s
period while seated, then blood pressure was recorded
from the right arm as an average value of two consecutive
blood pressure readings using a regular mercury sphygmo-
manometer in the same position. Laboratory tests included
fasting plasma glucose (FPG), fasting serum total choles-
terol (TC), low-density lipoprotein cholesterol (LDL-C),
high-density lipoprotein cholesterol (HDL-C), and trigly-
ceride (TG) by overnight blood samples drawn from the
antecubital vein. FPG, TC and TG were all determined
using the enzymatic method, while the concentration of
LDL-C was estimated using the Friedewald formula and
HDL-C was measured using the phosphotungstic acid/
magnesium chloride precipitation method [13]. Since 114
subjects were identified MS and seven subjects with heart
disease in 1992, they were excluded from the analysis. On
the other hand, since diabetes mellitus(DM) was just a
component of MS, we haven’t excluded it all at baseline.
Therefore, 590 subjects with complete data (male: 61.5 %)
were available and analysed. This study was approved by
Ministry of Health of China, as well as by the Ethics Com-
mittee of West China Hospital of Sichuan University. All
participants provided written informed consent.
Related definitions
The diagnosis of the metabolic syndrome was based on the
newly modified National Cholesterol Education Program
(NCEP) ATP III Criteria as proposed by the updated
American Heart Association (AHA)/National Heart, Lung,
and Blood Institute (NHLBI) scientific statement [1].
Accordingly, any 3 of the 5 following items constituted
diagnosis of metabolic syndrome: (1) waist circumference
≥80 cm in Asia women or ≥90 cm in Asia men; (2) fasting
triglyceride concentration ≥1.7 mmol/L or on drug treat-
ment for elevated triglycerides; (3) high density lipoprotein
cholesterol (HDL-C) concentration <1.3 mmol/L in
women or <1.0 mmol/L in men or on drug treatment for
reduced HDL-C; (4) blood pressure ≥130 mmHg (systolic)
or 85 mmHg (diastolic) or on antihypertensive drug treat-
ment in a patient with a history of hypertension; and (5)
fasting plasma glucose ≥5.6 mmol/L or on drug treatment
for elevated glucose. Smoking was defined as average
cigarette consumption ≥1/day. Alcohol intake was defined
as average intake of alcohol ≥50 g/week. Physical activity
was defined as exercise one or more times per week, at
least 20 min for each time.
Statistical analysis
Continuous data were presented as means ± standard de-
viations (SDs), and categorical variables were presented
as frequencies and percentages.
Differences of baseline characteristics between partici-
pants classified by genders were tested by Student’s t
tests for continuous data and chi-square tests for cat-
egorical data.
The difference in incidence of MS at follow-up between
two genders was tested by chi-square test too and the rela-
tionship between gender and incident MS at follow-up was
then tested by a multiple logistic regression analysis adjust-
ing for age, RHR, health related behaviors(including smok-
ing, drinking, and exercise) and pre-existing components
of MS, by taking gender as a categorical variable(0 =men,
1 = women).
After that, subjects were categorized into four groups ac-
cording to the baseline resting heart rate, that is, group
1(≤70 beats/min), group 2(71–80 beats/min), group 3(81–
90 beats/min) and group 4(>90 beats/min) in different
genders. Trend tests of MS incidences across the four cat-
egories of resting heart rate were conducted by Cochran-
Armitage tend tests in both men and women. Additionally,
to assess the effects of resting heart rate on the new onset
of MS in different genders, three logistic regression models
were used to estimate the odds ratios (ORs) and 95 % CI
values, by taking RHR as a continuous variable(per 4beats/
min elevation). In these analyses, model 1 was a univariate
model, included only RHR as the independent variable;
model 2 was adjusted for age and health related behavior-
s(included smoking, drinking, and exercise) and model 3
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was adjusted for age, health related behaviors and pre-
existing components of MS. Cochran-Armitage trend tests
were conducted using SAS software, version 6.12 (SAS In-
stitute Inc, Cary, NC) while the other statistical ana-
lyses were conducted using SPSS software version
18.0(SPSS, Chicago, IL). The statistical significance was
defined as P <0.05.
Results
Baseline characteristics of the participants in 1992
classified by genders
Table 1 shows the baseline characteristics of all partici-
pants in 1992 classified by genders. Of the 590 enrolled
participants, there were 227(38.5 %) women and 363
men (61.5 %). The baseline average age was 46 ± 6 years
in women and 49 ± 6 years in men. The women partici-
pants were younger than men. The percentages of smok-
ing and drinking in women were significantly lower than
in men, and the percentages of obesity, raised blood
pressure(BP), raised TG and decreased HDL in women
were significantly higher than in men.
Gender difference in incidence of MS at follow-up
The incidence of MS was 30.8 % in women and 17.6 %
in men over the 15-year follow-up period. The difference
in incidence of MS between two genders was statistically
significant(P <0.001). Multiple logistic regression analysis
showed that, after adjusting for age, RHR, health related
behaviors(including smoking, drinking, and exercise)
and pre-existing components of MS, gender(women)
itself was also an independent risk factor for incident
MS at follow-up(OR = 2.64, 1.33–5.23, P = 0.005).
Incidences of MS according to the RHR categories at
baseline classified by genders
As shown in Fig. 1, the incidences of MS over the 15-year
follow-up period in women according to the baseline RHR
categories were 13.0, 28.9, 36.8 and 42.3 %, in 23, 121, 57
and 26 participants respectively, and there was statistical
linear trend through the four groups (P for trend = 0.018)
for the 15 year period. In addition, the incidences of MS
over the 15-year follow-up period in men according to the
baseline RHR categories were 15.4, 16.1, 17.4 and 25.5 %,
in 52, 155, 109 and 47 participants respectively. There was
a raising trend across the four groups for the 15 year
period, but the linear trend didn’t reach statistical signifi-
cant (P for trend = 0.194).
Logistic regression analyses for the relationship of RHR at
baseline and incident MS at follow-up in different models
classified by genders
Table 2 shows the results of logistic regression analyses for
the relationship of RHR and incident MS in different
models. In women, each 4beats/min elevation in resting
heart rate was associated with an approximately 1.2-fold
increase in the risk of developing metabolic syndrome in a
univariate model(model 1, OR = 1.18, 1.03–1.36, P = 0.020)
and a multi-variate model adjusting for age and health
related behaviors only(model 2, OR = 1.20, 1.04–1.38,
P = 0.011). Additionally, after we adjusted for age, health
related behaviors and pre-existing components of MS
(model 3, OR = 1.23, 1.06–1.43, P = 0.007), the association
between the risk of developing metabolic syndrome and
tachycardia was still existed.
Otherwise, resting heart rate did not have any signifi-
cant associations with incident MS in men neither in a
univariate model nor in multivariate models.
Discussion
In this 15-year prospective follow-up study, we found
that elevated resting heart rate in the baseline is corre-
lated to the development of metabolic syndrome in the
follow-up in women rather than in men independent of
Table 1 Baseline characteristics of the participants in 1992
classified by genders
Women Men P value
Number(%) 227.0(38.5) 363.0(61.5) –
Age(years) 46 ± 6 49 ± 6 <0.001
Height 154.6 ± 5.4 165.2 ± 5.7 <0.001
Weight 54.9 ± 6.7 62.6 ± 8.0 <0.001
Waist(cm) 72.2 ± 6.3 77.4 ± 7.4 <0.001
BMI(kg/m2) 23.0 ± 2.4 22.9 ± 2.7 0.923
Smoking(n(%)) 1(0.4) 228(62.8) <0.001
Drinking(n(%)) 6(2.6) 210(57.9) <0.001
Exercise(n(%)) 46(20.3) 78(21.5) 0.723
RHR(beats/min) 79.9 ± 8.3 80.2 ± 9.4 0.632
SBP(mmHg) 109.9 ± 12.9 113.4 ± 12.8 0.001
DBP(mmHg) 71.3 ± 8.3 73.2 ± 8.5 0.011
FPG(mmol/L) 4.31 ± 1.12 4.26 ± 0.74 0.479
TG(mmol/L) 1.86 ± 0.73 2.04 ± 0.86 0.011
TC(mmol/L) 4.50 ± 0.80 4.42 ± 0.70 0.200
LDL(mmol/L) 2.32 ± 0.81 2.22 ± 0.78 0.103
HDL(mmol/L) 1.30 ± 0.24 1.24 ± 0.22 <0.001
Obesity(n(%)) 25(11.0) 16(4.4) 0.002
RBP(n(%)) 21(9.3) 64(17.6) 0.005
RFPG(n(%)) 7(3.1) 18(5.0) 0.271
RTG(n(%)) 97(42.7) 202(55.6) 0.002
DHDL(n(%)) 113(49.8) 57(15.7) <0.001
MS components 1.16 ± 0.73 0.98 ± 0.76 0.001
Data are presented as means ± SD or number (percentage)
BMI Body mass index, RHR Resting heart rate, SBP Systolic blood pressure, DBP
Diastolic blood pressure, FPG Fasting plasma glucose, TG Triglyceride, TC Total
cholesterol, LDL Low-density lipoprotein, HDL High-density lipoprotein, RBP
Raised blood pressure, RFPG Raised fasting plasma glucose, RTG Raised
triglyceride, DHDL Decreased high-density lipoprotein
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age, health related behaviors and any of MS compo-
nents. The incidence of MS increased with RHR elevated
in women while not in men. Our findings were not en-
tirely consistent with previous study results.
Some cross-sectional studies have already found a cor-
relation between RHR and MS in different populations
[14–18]. But they haven’t found gender differences in
the relationship between RHR and MS. Just in consistent
with previous studies [3–6], our study revealed that
there is significantly gender difference in the prevalence
of MS at follow-up, and the prevalence of MS in women
was higher than that in men at 15-year follow-up. Maybe
there are some differences in the pathogenesis of the
aggregation of multiple CVD risk factors in different
genders over time, so we think it is valuable to analysis
separately in men and women in longitudinal follow-up
studies. Just along with our opinions, Inoue et al. and
Oda et al. confirmed gender differences in their longitu-
dinal researches [7, 8]. Inoue et al. demonstrated that
men with elevated baseline heart rates were more likely
to experience metabolic syndrome than were those with
normal heart rates while it was not true for female pa-
tients over the 5-year period follow up [7], and Oda et
al. indicated that an increase in resting heart rate was a
significant risk factor for MS in non-obese Japanese men
but not in women through 3 years [8], but both of them
could not give a good explanation for the differences.
There was another prospective study that provided a dif-
ferent point of view. In this study, Zhang found that a
high resting heart rate is independently associated with
an increased risk of type 2 diabetes (an important com-
ponent of MS) in women during a mean follow-up of
4.9 years [19]. Although this study was not a direct evi-
dence to certify the relationship between RHR and MS
in women, it at least demonstrated that gender differ-
ences in the relationship between RHR and MS may re-
main controversial.
Our study is the first long time follow-up study of the
relationship between RHR at baseline and incident MS
15 years later. The relationship between RHR and inci-
dent MS was found in women, but not observed in men,
and the association was still exist in women when age,
health related behaviors and pre-existing components of
MS were adjusted for. The results of the study are differ-
ent in regard to gender differences in the relationship
between RHR and incident MS compared with previous
studies. It may be a chance result, but the participants in
our study are not the same as previous studies and there
are some rational explanations. First, the development of
MS and its associated components are chronic processes
and cannot come up in a short time. As a result, the
relationship between baseline RHR and incident MS
should be elucidated in a long observation time and
maybe confused by some potential factors in a relatively
short period of follow-up. Second, as influenced by
different genetic backgrounds, life styles and social en-
vironment factors, there may be differences in the
pathogenesis of MS in populations from different places.
Third, we adopted waist measurement as the component
Fig. 1 Incidences of MS according to the RHR categories at baseline. women P for trend = 0.018; men P for trend = 0.194
Table 2 Logistic regression analyses for the relationship
between RHR at baseline and incident MS at follow-up in
different models classified by genders
Women Men
OR 95 % CI P value OR 95 % CI P value
Model 1 1.18 1.03–1.36 0.020 1.08 0.97–1.21 0.177
Model 2 1.20 1.04–1.38 0.011 1.08 0.96–1.21 0.199
Model 3 1.23 1.06–1.43 0.007 1.08 0.96–1.22 0.218
Model 1: univariate model
Model 2: adjusted for age and health related behaviors(included smoking,
drinking, and exercise)
Model 3: adjusted for age, health related behaviors and pre-existing
components of MS
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of MS according to the newly published guideline [1],
while some researches just used BMI [7], which may not
be an appropriate indicator for MS. It is now widely ac-
cepted that insulin resistance is the most important
component of MS. Elevated sympathetic activity could
antagonise insulin’s effect on glucose uptake via effects
on blood flow(sympathetically mediated vasoconstric-
tion) in skeletal muscle, result in hyperinsulinemia and
insulin resistance [20, 21]. But gender differences exist
in the body reactions of sympathetic activation. Kneale
et al. demonstrated that young women exhibit blunted
vasoconstrictor responses to alpha-adrenergic stimula-
tion compared to men [22], which may be related to the
vasodilator effect of estrogen [23–28]. However, Vongpa-
tanasin indicated that menopause can lead to enhanced
alpha-adrenergic peripheral vasoconstriction both at rest
and during exercise [9] and Sherwood et al. demon-
strated that women exhibit altered sympathetic nervous
system activity and a sustained increase in hemodynamic
load after menopause [11]. Since the majority of the
women participants entered in our studies at the begin-
ning were in the perimenopause and in the elderly age
at the follow-up, we consider that the 15-year follow-up
may make the effect of sympathetic activation on metab-
olism more apparent in women. On the other hand, the
relationship between RHR and incident MS was weaker
in men than in women. Maybe it needed more men par-
ticipants to get statistically significant, particularly when
there was an increasing trend for men.
Our study has several limitations. First, we haven’t
adopted electrocardiogram as the measurement of resting
heart rate as most studies have. However, according to
Zhang [19], pulse palpation over a 30-s is an accepted
method too. Second, we haven’t completely eliminated the
effect of drugs on resting heart rate, but we have excluded
patients with heart disease in our study, those mostly
needed drugs with impacts on resting heart rate. Third,
we just used resting heart rate as the alternative indicator
of sympathetic activity, which is easily obtained, like most
studies, but it may not be an ideal surrogate for sympa-
thetic activity. Forth, MS is just a complex multifactorial
health problem, and it has limited practical utility as a
diagnostic or management tool, but it is worthwhile to
further elucidate the underlying pathways of the clustering
of such a lot of risk factors.
Conclusions
In conclusion, the present study reveals that elevated rest-
ing heart rate in middle age is an important risk factor for
developing MS in old age in women but not in men. The
inconsistency may be due to gender differences that exist
regarding bodily reactions to sympathetic activation, but
the mechanisms need to be further studied. On the other
hand, it is encouraging to explore the potential of direct
modulation of activity of the sympathetic nervous system
as a therapeutic strategy to prevent the development of
metabolic syndrome.
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